biote Corp. Files 8-K for Material Definitive Agreement

Ticker: BTMD · Form: 8-K · Filed: Jun 21, 2024 · CIK: 1819253

Sentiment: neutral

Topics: material-definitive-agreement, corporate-action, sec-filing

TL;DR

biote Corp. signed a big deal, filing an 8-K. Details to follow.

AI Summary

On June 14, 2024, biote Corp. entered into a material definitive agreement. The company, formerly known as Haymaker Acquisition Corp. III, is involved in the medicinal chemicals and botanical products industry. This filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Why It Matters

This filing indicates a significant contractual development for biote Corp., which could impact its business operations and financial standing. Investors should monitor subsequent disclosures for details on the agreement's terms and implications.

Risk Assessment

Risk Level: medium — The filing itself is procedural, but the 'material definitive agreement' could carry significant risks depending on its nature, which is not fully detailed in this initial report.

Key Numbers

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by biote Corp. on June 14, 2024?

The filing does not specify the exact nature of the material definitive agreement, only that one was entered into.

What was biote Corp.'s former name?

biote Corp.'s former name was Haymaker Acquisition Corp. III.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on June 14, 2024.

What is biote Corp.'s principal executive office address?

biote Corp.'s principal executive office is located at 1875 W. Walnut Hill Ln #100, Irving, Texas 75038.

What is the SIC code for biote Corp.?

The Standard Industrial Classification (SIC) code for biote Corp. is 2833, which corresponds to Medicinal Chemicals & Botanical Products.

Filing Stats: 906 words · 4 min read · ~3 pages · Grade level 11 · Accepted 2024-06-20 20:31:30

Key Financial Figures

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated June 20, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. biote Corp. By: /s/ Teresa S. Weber Name: Teresa S. Weber Title: Chief Executive Officer Date: June 20, 2024

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing